1. Home
  2. LibreView

Make more informed treatment decisions while saving time1 with LibreView*

Gather insights

After you establish a data sharing connection with your patients, you can access insightful glucose reports and metrics, enabling more productive conversations and more informed treatment decisions.

Ambulatory Glucose Profile (AGP) Report:

Using the AGP Report, you can make Time in Range (TIR) the standard of care when making treatment and dosing decisions for your patients.

AGP Report with TIR: Developed to align with the International Consensus on TIR standards2

For illustrative purposes only. Not actual patient data.

For illustrative purposes only. Not actual patient data.

Glucose Pattern Insights (GPI) Report:

Powered by LibreView*, the GPI report provides a guided interpretation of your patients’ continuous glucose monitoring (CGM) data.

You can:

  • Review overall glucose statistics to see your patients’ glycemic status and help you determine how much time they have spent below, within, and above target range.
  • Review medication and lifestyle considerations, which are based on the most important glucose pattern detected.

Daily Patterns Report

Shows glucose levels, carbohydrate intake data, and insulin administration data over a “typical” or average day during the reporting period

For illustrative purposes only. Not actual patient data.

For illustrative purposes only. Not actual patient data.

Weekly Summary

Provides a daily glucose summary for each day of the selected reporting period

Shows past glucose results to facilitate discussion with patients, in addition to:

  • Average glucose
  • Total carbs
  • Total insulin
  • Low events

 

* The LibreView data management software is intended for use by both patients and healthcare professionals to assist people with diabetes and their healthcare professionals in the review, analysis and evaluation of historical glucose meter data to support effective diabetes management. The LibreView software is not intended to provide treatment decisions or to be used as a substitute for professional healthcare advice.

† The user’s device must have internet connectivity for glucose data to automatically upload to LibreView and to transfer to connected LibreLinkUp app users.

‡ Default range is 70-180 mg/dL. Consult with a healthcare professional on individual target glucose range.

References: 1. Unger, Jeff, Pamela Kushner, and John E. Anderson. "Practical guidance for using the FreeStyle Libre flash continuous glucose monitoring in primary care." Postgraduate Medicine 132, no. 4 (2020): 305-313. https://doi.org/10.1080/00325481.2020.1744393. 2. Battelino, Tadej, et al. "Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on Time in Range." Diabetes Care 42, no. 8 (2019): 1593-1603. https://doi.org/10.2337/dci19-0028.  

ADC-52574 v2.0

Important Safety Information

FreeStyle Libre 14 day system: Failure to use FreeStyle Libre 14 day system as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855-632-8658 or FreeStyleLibre.us for safety info.

FreeStyle Libre 2 and FreeStyle Libre 3 systems: Failure to use FreeStyle Libre 2 or FreeStyle Libre 3 systems as instructed in labeling may result in missing a severe low or high glucose event and/or making a treatment decision, resulting in injury. If glucose alarms and readings do not match symptoms or expectations, use a fingerstick value from a blood glucose meter for treatment decisions. Seek medical attention when appropriate or contact Abbott at 855‑632‑8658 or FreeStyleLibre.us for safety info.

FreeStyle Libre Pro: The FreeStyle Libre Pro Flash Glucose Monitoring System is a professional continuous glucose monitoring (CGM) device indicated for detecting trends and tracking patterns and glucose level excursions above or below the desired range, facilitating therapy adjustments in persons (age 18 and older) with diabetes. The system is intended for use by health care professionals and requires a prescription.

IMPORTANT: The device may inaccurately indicate hypoglycemia. The results of the clinical study conducted for this device showed that 40% of the time when the device indicated that user sensor glucose values were at or below 60 mg/dL, user glucose values were actually in the range of 81-160 mg/dL. Therefore, interpretation of the FreeStyle Libre Pro Flash Glucose Monitoring System readings should only be based on the trends and patterns analyzed through time using the reports available per the intended use.

CONTRAINDICATIONS: Remove the Sensor before MRI, CT scan, X-ray, or diathermy treatment.

WARNINGS/LIMITATIONS: The FreeStyle Libre Pro System does not provide real-time results and patients should adhere to their blood glucose monitoring routine while using the system. If a sensor breaks, contact physician and call Customer Service. Patients with high levels of ascorbic acid (Vitamin C) or salicylic acid (used in Aspirin) or severe dehydration or excessive water loss may experience inaccurate results with this system. The FreeStyle Libre Pro System is not approved for pregnant women, persons on dialysis, or recommended for critically-ill population. Sensor placement is not approved for sites other than the back of the arm and standard precautions for transmission of blood borne pathogens should be taken. Review all product information before use or contact Abbott Toll Free (855-632-5297) (or visit provider.myfreestyle.com) for detailed indications for use and safety information.

The product images are for illustrative purposes only.

The sensor housing, FreeStyle, Libre, and related brand marks are marks of Abbott. Other trademarks are the property of their respective owners.

No use of any Abbott trademark, trade name, or trade dress in this site may be made without prior written authorization of Abbott Laboratories, except to identify the product or services of the company.

This website and the information contained herein is intended for use by residents of the United States.

ADC-45115 v17.0